A detailed history of Sherbrooke Park Advisers LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 2,186 shares of MEDP stock, worth $752,137. This represents 0.17% of its overall portfolio holdings.

Number of Shares
2,186
Previous 3,018 27.57%
Holding current value
$752,137
Previous $1.24 Billion 41.29%
% of portfolio
0.17%
Previous 0.22%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$320.58 - $457.29 $266,722 - $380,465
-832 Reduced 27.57%
2,186 $730 Million
Q2 2024

Aug 14, 2024

BUY
$372.0 - $424.34 $1.12 Million - $1.28 Million
3,018 New
3,018 $1.24 Billion

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.7B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.